Real-time enrollment status for this retinopathy of prematurity (rop) clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 5:44 AM UTC
| NCT Number | NCT07093255 |
| Recruiting Status | Recruiting |
| Condition | Retinopathy of Prematurity (ROP) |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | FELIQS INC. |
| Last Updated on CT.gov | October 13, 2026 (4 days ago) |
As of October 17, 2026: Clinical trial NCT07093255 is currently recruiting participants. This phase1 study for retinopathy of prematurity (rop) is actively seeking new participants at 1 location across the United States. The study is sponsored by FELIQS INC.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07093255 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07093255 was last updated 4 days ago (October 13, 2026). HelloStudys verifies this status automatically.